3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
539
Neoplasms
482
Carcinoma, Non-Small-Cell Lung
395
Prostatic Neoplasms
314
Colorectal Neoplasms
300
Lung Neoplasms
265
Neoplasm Metastasis
222
Ovarian Neoplasms
199
Leukemia, Myeloid, Acute
197
Pancreatic Neoplasms
187
Multiple Myeloma
174
Recurrence
135
Squamous Cell Carcinoma of Head and Neck
133
Stomach Neoplasms
131
Brain Neoplasms
131
Melanoma
127
Carcinoma, Hepatocellular
126
Glioblastoma
121
Endometrial Neoplasms
121
Triple Negative Breast Neoplasms
113
Precursor Cell Lymphoblastic Leukemia-Lymphoma
106
Hematologic Neoplasms
104
Head and Neck Neoplasms
100
Carcinoma, Renal Cell
98
Lymphoma
96
Urinary Bladder Neoplasms
93
Sarcoma
91
Glioma
88
Rectal Neoplasms
83
Small Cell Lung Carcinoma
82
Interventions
ribociclib
1
palbociclib
1
abemaciclib
1
AZD9833
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
ER+ HER2- Advanced Breast Cancer
×
90 days
×
Clear all
NCT06188520
2026-05-11
CYCAD-1
AstraZeneca
Phase 1/2
Recruiting
564 enrolled